New Prodrugs of the Antiprotozoal Drug Pentamidine

Joscha Kotthaus, Jürke Kotthaus, Dennis Schade, Ulrike Schwering, Helen Hungeling, Helge Müller-Fielitz, Walter Raasch, Bernd Clement*

*Korrespondierende/r Autor/-in für diese Arbeit
11 Zitate (Scopus)

Abstract

Pentamidine is an effective antimicrobial agent that is approved for the treatment of African trypanosomiasis but suffers from poor oral bioavailability and central nervous system (CNS) penetration. This work deals with the development and systematic characterisation of new prodrugs of pentamidine. For this reason, numerous prodrugs that use different prodrug principles were synthesised and examined invitro and invivo. Another objective of the study was the determination of permeability of the different pentamidine prodrugs. While some of the prodrug principles applied in this study are known, such as the conversion of the amidine functions into amidoximes or the O-alkylation of amidoximes with a carboxymethyl residue, others were developed more recently and are described here for the first time. These newly developed methods aim to increase the affinity of the prodrug for the transporters and mediate an active uptake via carrier systems by conjugation of amidoximes with compounds that improve the overall solubility of the prodrug. The different principles chosen resulted in several pentamidine prodrugs with various advantages. The objective of this investigation was the systematic characterisation and evaluation of eight pentamidine prodrugs in order to identify the most appropriate strategy to improve the properties of the parent drug. For this reason, all prodrugs were examined with respect to their solubility, stability, enzymatic activation, distribution, CNS delivery, and oral bioavailability. The results of this work have allowed reliable conclusions to be drawn regarding the best prodrug principle for the antiprotozoal drug pentamidine. Weighing the pros and cons: The systematic development and characterisation of novel prodrugs of the antiprotozoal drug pentamidine is described. The prodrug principles applied use different enzyme systems for activation and target both passive and active uptake mechanisms. Through the synthesis and invitro and invivo evaluation of eight novel prodrugs, reliable conclusions regarding the most appropriate prodrug principle for this drug were drawn.

OriginalspracheEnglisch
ZeitschriftChemMedChem
Jahrgang6
Ausgabenummer12
Seiten (von - bis)2233-2242
Seitenumfang10
ISSN1860-7179
DOIs
PublikationsstatusVeröffentlicht - 09.12.2011

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Untersuchen Sie die Forschungsthemen von „New Prodrugs of the Antiprotozoal Drug Pentamidine“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren